Sack, Circuit Judge:
Pfizer, Inc. produces and sells a drug called tafamidis, which treats a rare, progressive heart condition known as transthyretin amyloid cardiomyopathy ("ATTR-CM"). Tafamidis is considered a breakthrough treatment — it is currently the only drug approved by the United States Food and Drug Administration ("FDA") to treat...
Let's get started
Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.
- Updated daily.
- Uncompromising quality.
- Complete, Accurate, Current.